Literature DB >> 33664225

Hepatic HuR protects against the pathogenesis of non-alcoholic fatty liver disease by targeting PTEN.

Mi Tian1,2, Jingjing Wang3, Shangming Liu4, Xinyun Li1, Jingyuan Li1, Jianmin Yang1, Cheng Zhang1, Wencheng Zhang5,6.   

Abstract

The liver plays an important role in lipid and glucose metabolism. Here, we show the role of human antigen R (HuR), an RNA regulator protein, in hepatocyte steatosis and glucose metabolism. We investigated the level of HuR in the liver of mice fed a normal chow diet (NCD) and a high-fat diet (HFD). HuR was downregulated in the livers of HFD-fed mice. Liver-specific HuR knockout (HuRLKO) mice showed exacerbated HFD-induced hepatic steatosis along with enhanced glucose tolerance as compared with control mice. Mechanistically, HuR could bind to the adenylate uridylate-rich elements of phosphatase and tensin homolog deleted on the chromosome 10 (PTEN) mRNA 3' untranslated region, resulting in the increased stability of Pten mRNA; genetic knockdown of HuR decreased the expression of PTEN. Finally, lentiviral overexpression of PTEN alleviated the development of hepatic steatosis in HuRLKO mice in vivo. Overall, HuR regulates lipid and glucose metabolism by targeting PTEN.

Entities:  

Year:  2021        PMID: 33664225      PMCID: PMC7933173          DOI: 10.1038/s41419-021-03514-0

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  33 in total

1.  p85 Associates with unphosphorylated PTEN and the PTEN-associated complex.

Authors:  Rosalia Rabinovsky; Panisa Pochanard; Chontelle McNear; Saskia M Brachmann; Jonathan S Duke-Cohan; Levi A Garraway; William R Sellers
Journal:  Mol Cell Biol       Date:  2009-07-27       Impact factor: 4.272

Review 2.  Progress and challenges in the prevention and control of nonalcoholic fatty liver disease.

Authors:  Jingjing Cai; Xiao-Jing Zhang; Hongliang Li
Journal:  Med Res Rev       Date:  2018-05-30       Impact factor: 12.944

3.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

4.  Reversible inactivation of the tumor suppressor PTEN by H2O2.

Authors:  Seung-Rock Lee; Kap-Seok Yang; Jaeyul Kwon; Chunghee Lee; Woojin Jeong; Sue Goo Rhee
Journal:  J Biol Chem       Date:  2002-03-26       Impact factor: 5.157

5.  Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein.

Authors:  W J Ma; S Cheng; C Campbell; A Wright; H Furneaux
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

6.  Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice.

Authors:  Marion Peyrou; Lucie Bourgoin; Anne-Laure Poher; Jordi Altirriba; Christine Maeder; Aurélie Caillon; Margot Fournier; Xavier Montet; Françoise Rohner-Jeanrenaud; Michelangelo Foti
Journal:  J Hepatol       Date:  2014-09-16       Impact factor: 25.083

Review 7.  The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Christos Zavos; Eleni Tsiaousi
Journal:  Diabetes Obes Metab       Date:  2010-05       Impact factor: 6.577

8.  Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected].

Authors:  Bangyan Stiles; Ying Wang; Andreas Stahl; Sara Bassilian; W Paul Lee; Yoon-Jung Kim; Robert Sherwin; Sherin Devaskar; Ralf Lesche; Mark A Magnuson; Hong Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

9.  Both HuR and miR-29s regulate expression of CB1 involved in infiltration of bone marrow monocyte/macrophage in chronic liver injury.

Authors:  Na Chang; Xianghui Duan; Zhongxin Zhao; Lei Tian; Xiaofang Ji; Lin Yang; Liying Li
Journal:  J Cell Physiol       Date:  2019-09-08       Impact factor: 6.384

10.  Hepatic HuR modulates lipid homeostasis in response to high-fat diet.

Authors:  Zhuojun Zhang; Chen Zong; Mingyang Jiang; Han Hu; Xiaolei Cheng; Juhua Ni; Xia Yi; Bin Jiang; Feng Tian; Ming-Wen Chang; Wen Su; Lijun Zhu; Jinfan Li; Xueping Xiang; Congxiu Miao; Myriam Gorospe; Rafael de Cabo; Yali Dou; Zhenyu Ju; Jichun Yang; Changtao Jiang; Zhongzhou Yang; Wengong Wang
Journal:  Nat Commun       Date:  2020-06-16       Impact factor: 14.919

View more
  3 in total

1.  Priming, Triggering, Adaptation and Senescence (PTAS): A Hypothesis for a Common Damage Mechanism of Steatohepatitis.

Authors:  Peter M Abuja; Kurt Zatloukal; Helmut Denk
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

2.  RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression.

Authors:  Yanyan Wang; Yun-Ling Tai; Grayson Way; Jing Zeng; Derrick Zhao; Lianyong Su; Xixian Jiang; Kaitlyn G Jackson; Xuan Wang; Emily C Gurley; Jinze Liu; Jinpeng Liu; Weidong Chen; Xiang-Yang Wang; Arun J Sanyal; Phillip B Hylemon; Huiping Zhou
Journal:  Cell Biosci       Date:  2022-10-12       Impact factor: 9.584

3.  PARK7 deficiency inhibits fatty acid β-oxidation via PTEN to delay liver regeneration after hepatectomy.

Authors:  Xiaoye Qu; Yankai Wen; Junzhe Jiao; Jie Zhao; Xuehua Sun; Fang Wang; Yueqiu Gao; Weifeng Tan; Qiang Xia; Hailong Wu; Xiaoni Kong
Journal:  Clin Transl Med       Date:  2022-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.